Jump to section
To continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health.
Human genomics research and related biotechnologies has the potential to achieve a number of public health goals, such as to reduce global health inequalities. Ultima Genomics is a genomic sequencing machine and software platform striving to make advances in biology and human health.
The company has developed a new approach to sequencing at scale, leveraging a new architecture to go beyond conventional sequencing technologies and lower the cost of genomic information. This has enabled the company to attract serious funding from top tier investors.
Boasting a team filled with successful entrepreneurs to molecular and computational biologists, Ultima Genomics is fast becoming a leader in its field. Partnering with several companies to further research and capability, the company most recently joined forces with Regeneron to marry minds toward drug discovery and development.
Kirsty
Company Specialist at Welcome to the Jungle
Jun 2022
$600m
LATE VC
May 2022
$3.6m
GRANT
This company has top investors
Gilad Almogy
(CEO)Previously Senior Vice President of Applied Materials. Also Founder and CEO of Cogenra Solar.
Mark Pratt
(CTO)Worked as a Consultant and Principal Engineer at 10X Genomics. Owner of Voyager Technologies, LLC.